Patent dispute over generic paracetamol on hold

Initial claims have been dismissed, but there is an opportunity to make further submissions on both sides GlaxoSmithKline’s legal proceeding against Apotex and Generic Partners over its paracetamol products has been dismissed, as has Apotex and Generic Partner’s cross claim. The patent claim in question covered a pharmaceutical composition comprising: “a bilayer tablet having an